The beat, raised guidance, and increased buyback authorization signal strong operational execution and management confidence. Monitor for continued same-store discharge growth and margin expansion from new hospital openings in H2 2026; the raised revenue and EPS guidance sets a higher bar for Q3 and Q4.
Price Chart
Executive Summary
Encompass Health reported Q2 2026 diluted EPS of $1.55, beating consensus of $1.48 by 4.7%, and net operating revenue of $1.597B, slightly above the $1.57B consensus. The company raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS, and expanded its stock repurchase authorization to $1 billion, reflecting confidence in continued strong operational performance.
Key Financial Metrics
Key Facts
- Q2 2026 diluted EPS from continuing operations $1.55 vs consensus $1.48 (beat by 4.7%)
- Net operating revenue $1,597.4M vs consensus $1,570M (beat by 1.7%)
- Revenue grew 9.6% YoY; Adjusted EBITDA grew 9.2% YoY to $348.0M
- Full-year 2026 guidance raised: revenue to $6,410-$6,490M, adjusted EPS to $6.02-$6.25
- Board increased stock repurchase authorization to $1 billion; $145.8M repurchased YTD
- Same-store discharge growth 2.8%; total discharges up 5.6% YoY
Financial Impact
EPS beat of $0.07 (4.7%) and revenue beat of $27.4M (1.7%) with raised full-year guidance midpoint for EPS by $0.13-0.14 and revenue by $35M at midpoint
Risk Factors
- Labor cost inflation and staffing shortages could pressure margins
- Medicare/Medicaid reimbursement changes or regulatory shifts
- Execution risk on planned hospital openings and bed additions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302844091 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | Insider Cluster | $122.05 $121.49 | ▼ −0.46% | ▼ −0.78% | $118.93 (−2.56%) |
Aug 11, 2026 7w ago | Insider Cluster | $125.35 $121.37 | ▲ +3.17% | ▲ +2.11% | $118.93 (+5.12%) |
Aug 5, 2026 8w ago | Press Release | $124.82 $122.59 | ▼ −1.79% | ▼ −2.39% | $118.93 (−4.72%) |
Jul 9, 2026 12w ago | Press Release | $110.16 $125.23 | ▲ +13.68% | ▲ +11.25% | $118.93 (+7.96%) |
Jun 1, 2026 17w ago | 8-K | $101.19 $101.39 | ▲ +0.19% | ▲ +2.01% | $118.93 (+17.53%) |
May 15, 2026 19w ago | 8-K | $106.54 $99.36 | ▼ −6.74% | ▼ −8.86% | $118.93 (+11.63%) |
Apr 30, 2026 22w ago | 8-K | $107.38 $102.19 | ▼ −4.83% | ▼ −10.10% | $118.93 (+10.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access